Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCL2L1 anticorps

Cet anticorps anti-BCL2L1 est un anticorps Souris Monoclonal détectant BCL2L1 dans FACS. Adapté pour Humain. Ce Primary Antibody a été cité dans 1 publication.
N° du produit ABIN135021

Aperçu rapide pour BCL2L1 anticorps (ABIN135021)

Antigène

Voir toutes BCL2L1 Anticorps
BCL2L1 (BCL2-Like 1 (BCL2L1))

Reactivité

  • 221
  • 129
  • 114
  • 50
  • 25
  • 12
  • 10
  • 9
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Humain

Hôte

  • 156
  • 89
  • 1
Souris

Clonalité

  • 142
  • 104
Monoclonal

Conjugué

  • 119
  • 27
  • 11
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BCL2L1 est non-conjugé

Application

  • 164
  • 84
  • 63
  • 54
  • 53
  • 33
  • 28
  • 28
  • 25
  • 25
  • 21
  • 11
  • 10
  • 7
  • 6
  • 4
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Clone

7B2-5
  • Specificité

    Human/Mouse/Rat/Rhesus Bcl-xL

    Attributs du produit

    Mouse Anti-Bcl-xL-UNLB

    Purification

    Purified

    Immunogène

    Recombinant human Bcl-xS

    Isotype

    IgG3
  • Indications d'application

    • Applications: FC - Quality tested , IHC-PS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , IP - Reported in literature , ELISA - Reported in literature
    • Working Dilutions: Flow Cytometry FITC and BIOT conjugates 3 g/106 cells PE conjugate 0.3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 1 g/mL

    Volume d'échantillon

    1 mL

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

    Agent conservateur

    Without preservative

    Conseil sur la manipulation

    Each reagent is stable for the period shown on the bottle label if stored as directed.

    Stock

    4 °C

    Stockage commentaire

    Store at 2-8°C
  • Gottschalk, Boise, Oltvai, Accavitti, Korsmeyer, Quintáns, Thompson: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." dans: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).

  • Antigène

    BCL2L1 (BCL2-Like 1 (BCL2L1))

    Autre désignation

    Bcl-xL

    Sujet

    Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment. Bcl-2 and one of its homologues, Bcl-xL, protect cells from apoptosis, while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis. Bcl-xL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. In contrast, Bad and Bax inhibit the protective functions of Bcl-xL and Bcl-2, respectively. Although heterodimerization between Bcl-xL/Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-xL and Bcl-2, other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity.

    Pathways

    Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Vous êtes ici:
Chat with us!